Management

Niklas has extensive experience from the global biotech and pharma industry and has held leadership positions in research-focused pharmaceutical companies such as Merck/MSD and Pfizer, with both Sweden and the US as a base. He has also been CEO and board member/chairperson of several medtech and biotech companies such as Medivir and CellaVision, and has experience from both private and public ownership. Niklas holds an MSc in Economics and Business Administration from Stockholm School of Economics, and completed an MBA in Marketing at the University of Michigan.

Nina is a trained neuroscientist with extensive experience within Cell and Gene Therapies. She has in her early career held technical and commercial roles at the Scottish Center for Regenerative Medicine and the Cell and Gene Therapy Catapult. More recently, she established Lonza’s autologous cell therapy offering and managed the Cocoon technology, and as the Chief Commercial Officer led FloDesign Sonics through market entry and acquisition by Merck KGaA, where she continued as a commercial leader. Nina has a PhD in Neuroscience from Carl Von Ossietzky University Oldenburg and an MBA from the University of Edinburgh.

Johan has a broad experience in both executive and advisory roles across a variety of industries. He has served as COO and CEO of Bactiguard and was Head of Business Sweden in Japan. His background also includes investment banking at SEB and consulting at McKinsey and Bain. Johan holds an MSc in Business and Economics and Stockholm School of Economics.

Ricardo is a biotech engineer bringing extensive global experience in Cell and Gene Therapy. He has managed technical teams at CCRM, Cell Gene Therapy Catapult, Cellectis, ProCella, and Alder, focusing on scalable bioprocess and analytical solutions. He was involved in the generation of induced pluripotent stem cell lines in GMP, and on the design of GMP facilities for the large-scale manufacturing of cell and gene therapies. Ricardo has a PhD in Bioengineering from Instituto Superior Técnico and post-doctoral training at Peter Zandstra’s Stem Cell Bioengineering Lab.

Staffan is one of the founders of SmartCella and Professor in Clinical Neuroimaging at the department of Clinical Neuroscience, Karolinska Institutet. He is also Senior physician/Consultant in endovascular neurointerventional procedures in the department of Neuroradiology, University Hospital, as well as research group leader who has published widely on novel neuroimaging and interventional techniques. In 2016, he gave the Seldinger Honorary Lecture at the European Congress of Radiology. In 2020, he received the Hans Wigzell Foundation Science Prize and in 2022 he received the Karolinska Institutet prize for Innovation and Utilization.

Jonathan is an accomplished medical professional with a distinguished career in cardiology. He earned his medical degree at Harvard Medical School and completed his internal Medicine Training at NYPH-Weil Cornell Cardiology Center. Jonathan further specialized with a cardiology fellowship at Massachusetts General Hospital. His research work at Karolinska Institutet focused on novel cardiac stem cell, RNA therapies, and catheter delivery systems for heart disease.

Kylie is a neuroscientist by training with a strong background in translational stem cell research. She holds a PhD in Neuroscience from Karolinska Institutet and was a research fellow at Columbia University, focusing on diabetes. Her discovery at Karolinska Institutet on cardiac stem cell therapy for treatment of heart disease formed the scientific foundation of ProCella. She was an Assistant Professor at Karolinska Institutet prior to joining SmartCella.

Oskar is a seasoned financial professional with extensive expertise in the Healthcare field stemming from his background in Private Equity and Investment Banking, focusing on Healthcare investments. He holds a MSc in Business and Economics from Stockholm School of Economics and HEC Paris, with a focus on Accounting and Finance. Oskar’s prior experiences includes roles at Morgan Stanley Healthcare. Altor Private Equity, Novo Holdings and Impilo Private Equity.

Ann Fredriksson has extensive experience of senior HR and management positions from fast growing international businesses within Medtech, Biotech, IT and Software, companies such as Vironova AB and Jeeves Information Systems AB. She is a business-oriented HR professional with a sales & marketing background and has broad experience of working with organizations in change. Ann has held leadership positions at a strategic and operational level for more than 20 years and her competence covers the entire HR area with an emphasis on development and change management.